Threonine

Threonine

SCHEMBL92730

CC(O)[C@@H](N)C(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Allothreonine SCHEMBL222076 1.00
Threonine SCHEMBL16111860 1.00 SLC7A5 (0.63)
Threonine SCHEMBL9461237 1.00 SLC7A5 (0.63)
Threonine SCHEMBL6038228 1.00 SLC7A5 (0.63)
Threonine SCHEMBL14946556 1.00
Threonine SCHEMBL2702066 1.00 SLC7A5 (0.63)
Threonine SCHEMBL18050157 1.00 SLC7A5 (0.63)
Threonine SCHEMBL18050155 1.00 SLC7A5 (0.63)
Threonine SCHEMBL117301 1.00
Threonine SCHEMBL1480 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6430 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125442-A1 PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST LILLY CO ELI (US) 2026-05-07 US claimed
US-20260098072-A1 METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS ENDEVICA BIO INC (US) 2026-04-09 US claimed
US-20260061085-A1 CYCLIC PEPTIDE AND PREPARATION METHOD THEREFOR, AND COMPLEX COMPRISING SAME AND USE THEREOF HEXIN SUZHOU PHARMACEUTICAL TECH CO LTD (CN) 2026-03-05 US claimed
US-20260001910-A1 PEPTIDES AND USES THEREOF PREVECEUTICAL MEDICAL INC (CA) 2026-01-01 US claimed
EP-4665374-A1 METHODS OF PREVENTING AND/OR TREATING SIDE EFFECTS ASSOCIATED WITH ANTI-CANCER AGENTS USING NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS WITH ANTI-GDF-15 ANTIBODIES Endevica Bio, Inc. (US) 2025-12-24 EP claimed
WO-2025245279-A1 NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USE THEREFORE IN TREATMENT OF ADDICTION AND/OR PAIN ENDEVICA BIO, INC. (US) 2025-11-27 WO claimed
US-20250353797-A1 ENDOPHYTES, ASSOCIATED COMPOSITIONS, AND METHODS OF USE INDIGO AG INC (US) 2025-11-20 US claimed
US-20250332226-A1 COMPOSITIONS AND METHODS FOR TREATING SOLID CANCER EXOXEMIS INC (US) 2025-10-30 US claimed
US-12441765-B2 Peptides and medical uses thereof ANBITION S.R.L. (IT) 2025-10-14 US claimed
US-20250282837-A1 METHOD AND COMPOSITIONS FOR NEURONAL REPROGRAMMING SUNNYBROOK RES INST (CA) 2025-09-11 US claimed
US-4127524-A ANALGESIC VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY 1978-11-28 US claimed
US-4127537-A ANALGESIC VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY 1978-11-28 US claimed
US-4127536-A ANALGESIC VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY 1978-11-28 US claimed
US-4127530-A ANALGESIC VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY 1978-11-28 US claimed
US-4127531-A ANALGESIC VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY 1978-11-28 US claimed
US-4127528-A HEXADECAPEPTIDE, ANALGESIC VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY 1978-11-28 US claimed
US-4127529-A ANALGESIC VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY 1978-11-28 US claimed
US-4127533-A ANALGESIC VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY 1978-11-28 US claimed
US-4127541-A ANALGESIC VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY 1978-11-28 US claimed
US-4127540-A Novel derivatives of δ-endorphins, intermediates therefor, and compositions and methods employing said derivatives VETERANS ADMINISTRATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY 1978-11-28 US claimed